Here's what to expect from Commonwealth Bank of Australia's interim report

Commonwealth Bank of Australia (ASX:CBA) will deliver its interim results on Wednesday. Will it impress the market?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

All eyes will be on Commonwealth Bank of Australia (ASX: CBA) this week with Australia's largest bank tipped to announce a record interim profit when it reports on Wednesday.

Investors have pushed the bank's stock to new all-time highs and will be hoping for a half-year profit of $4.56 billion, according to the Fairfax press, which compares to the $4.2 billion it reported in the first half of 2014. This could also pave the way for a $2.00 per share interim dividend, which would reflect a 9% increase on the $1.83 paid to shareholders last year.

It is expected that a number of factors will play in the bank's favour, including lower bad debt charges and a pick-up in credit growth. Meanwhile, the big four banks have also made significant cuts to the interest paid on term deposits which should also provide a decent boost for earnings.

As it stands, Commonwealth Bank shares are trading at $92.98, giving the company a market capitalisation over $150 billion. At that price, the stock is trading on a projected price-earnings multiple of 16.5 times, making it one of the most expensive bank stocks in the world – and far more expensive than any of its three major rivals.

As such, investors will be extremely critical of the bank's performance for its first-half operations. Rather than simply focusing on the profit result however, investors will also be looking at factors such as the bank's net interest margin (the profit it makes on its loans) as well as any move the bank might make that would indicate it is concerned about its level of capital in response to the financial system inquiry late last year. This could indicate either slower dividend growth or perhaps a dilution of shareholders' equity in the future, neither of which would sit particularly well with investors.

Regardless of the result however, Commonwealth Bank presents as a very expensive investment prospect and investors would be wise to look at some of the market's other compelling opportunities.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »